Biomedical Engineering Reference
In-Depth Information
64. Trollet, C., Scherman, D., Bigey, P., 2008, “Delivery of DNA into muscle for
treating systemic diseases: advantages and challenges,” Methods Mol. Biol.,
423, pp. 199-214.
65. O'Brien, J.A., Holt, M., Whiteside, G., Lummis, S.C., Hastings, M.H., 2001,
“Modifications to the hand-held Gene Gun: improvements for in vitro biolistic
transfection of organotypic neuronal tissue,” J. Neurosci. Methods, 112,
pp. 57-64.
66. Guo, S., Huang, Y., Zhang, W., Wang, W., Wei, T., et al., 2011,
“ Ternary complexes of amphiphilic polycaprolactone-graft-poly(N,N-
dimethylaminoethylmethacrylate), DNA and polyglutamic acid-graft-poly
(ethylene glycol) for gene delivery,” Biomaterials, 32, pp. 4283-4292.
67. Lee, S.H., Choi, S.H., Kim, S.H., Park, T.G., 2008, “Thermally sensitive
cationic polymer nanocapsules for specific cytosolic delivery and efficient gene
silencing of siRNA: swelling induced physical disruption of endosome by cold
shock,” J. Control Release, 125, pp. 25-32.
68. Weber, N., Ortega, P., Clemente, M.I., Shcharbin, D., Bryszewska, M., et
al., 2008, “Characterization of carbosilane dendrimers as effective carriers of
siRNA to HIV-infected lymphocytes,” J. Control Release, 132, pp. 55-64.
69. Chono, S., Li, S.D., Conwell, C.C., Huang, L., 2008, “An efficient and low
immunostimulatory nanoparticle formulation for systemic siRNA delivery to
the tumor,” J. Control Release, 131, pp. 64-69.
70. Hu, D., Gong. P., Ma, Y., Cai, L., 2009, “Research advancement and prospects
of nanotechnology in early diagnosis and treatment of cancer,” Chinese
J. Cancer, 28, pp. 1-7.
71. Kumari, A., Yadav, K.S., Yadav, S.C., 2010, “Biodegradable polymeric
nanoparticles based drug delivery systems,” Colloids and Surfaces B:
Biointerfaces, 75, pp. 1-8.
72. Kateb, B., Chiu, K., Black, K.L., Yamamoto, V., Khalsa, B., 2011,
“Nanoplatforms for constructing new approaches to cancer treatment,
imaging, and drug delivery: What should be the policy?” NeuroImage, 54,
pp. S106-S124.
73. Rozkhova, E.A., 2011, “Nanoscale materials for tackling brain cancer: recent
progress and outlook,” Adv. Mater., 23, pp. 136-150.
74. Jain, K.K., 2005, “Nanotechnology in clinical laboratory diagnostics,” Clin.
Chim. Acta, 358, pp. 37-54.
75. Wang, Y.X., Hussain, S.M., Krestin, G.P., 2011, “Superparamagnetic iron
oxide contrast agents: physicochemical characteristics and applications in MR
imaging,” Eur. Radiol., 11, pp. 2319-2331.
76. Neuwelt, E.A., Várallyay, P., Bagó, A.G., et al., 2004, “Imaging of iron oxide
nanoparticles by MR and light microscopy in patients with malignant brain
tumours,” Neuropathol. Appl. Neurobiol., 30, pp. 456-471.
77. Salata, O.V., 2004, “Applications of nanoparticles in biology and medicine,”
J. Nanobiotechnology, 2, p. 3.
78. Hede, S., and Huilgol, N., 2006, “Nano: The new nemesis of cancer,” J. Cancer
Res. her., 2, pp. 186-195.
79. Perou, C.M., Sørlie, T., Eisen, M.B., Rijn, M., Jeffrey, S.S., et al., 2000,
“Molecular portraits of breast tumours,” Nature, 406, pp. 747-752.
